# Marker Therapeutics, Inc.: Form 8-K, filed Apr 8, 2024

- Company: [Marker Therapeutics, Inc.](/companies/mrkr.md) (CIK 1094038)
- Form: 8-K
- Filed: 2024-04-08
- Accepted by EDGAR: Apr 8, 2024, 11:09 ET
- Period: 2024-04-08
- Accession: 0001104659-24-044496
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1094038/000110465924044496/tm2411143d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1094038/000110465924044496/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1094038/000110465924044496/tm2411143d1_8k.htm

Filed Apr 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-044496. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.